Literature DB >> 12371532

Urticaria to cetirizine.

R Tella1, P Gaig, J Bartra, P Garcia-Ortega.   

Abstract

A patient with recurrent idiopathic urticaria reported exacerbations after treatment with cetirizine. Prick test to cetirizine was negative. Double-blind challenge tests with mizolastine, loratadine, fexofenadine, dexchlorpheniramine, ebastine, ketotifen, and placebo were negative, whereas hydroxyzine and its active metabolite, cetirizine, reproduced the urticaria. Identification of uncommon adverse reactions to H1 antihistamines is important, particularly because they may mimic the underlying disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12371532

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  4 in total

1.  Cetirizine-induced anaphylaxis: a rare adverse drug reaction.

Authors:  Nisha Afonso; Pankaj Shetgaonkar; Amit Dang; Padmanabh V Rataboli
Journal:  Br J Clin Pharmacol       Date:  2009-02-23       Impact factor: 4.335

Review 2.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Cetirizine: a review of its use in allergic disorders.

Authors:  Monique P Curran; Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Fexofenadine-induced urticaria.

Authors:  Sang Woo Lee; Ji Yeon Byun; You Won Choi; Ki Bum Myung; Hae Young Choi
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.